Jingjin Li

4.6k total citations · 1 hit paper
85 papers, 2.1k citations indexed

About

Jingjin Li is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jingjin Li has authored 85 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Oncology and 15 papers in Genetics. Recurrent topics in Jingjin Li's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), CAR-T cell therapy research (9 papers) and Cancer-related molecular mechanisms research (8 papers). Jingjin Li is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), CAR-T cell therapy research (9 papers) and Cancer-related molecular mechanisms research (8 papers). Jingjin Li collaborates with scholars based in China, United States and France. Jingjin Li's co-authors include Srđan Verstovšek, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, Mark M. Jones, Tamás Masszi, Martin Grießhammer, Francesco Passamonti, Pierre Zachée, Fabrizio Pane and Ruben A. Mesa and has published in prestigious journals such as New England Journal of Medicine, Advanced Materials and Nature Communications.

In The Last Decade

Jingjin Li

81 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

2015 594 citations Jingjin Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jingjin Li China	23	780	619	494	412	287	85	2.1k
Janette Lamb United States	24	838 1.1×	659 1.1×	475 1.0×	308 0.7×	209 0.7×	45	2.6k
Ian J. Cohen Israel	33	802 1.0×	535 0.9×	463 0.9×	336 0.8×	212 0.7×	160	3.4k
Sonja Pavlović Serbia	23	741 0.9×	344 0.6×	371 0.8×	205 0.5×	227 0.8×	180	1.9k
Mariko Eguchi Japan	24	832 1.1×	249 0.4×	845 1.7×	306 0.7×	85 0.3×	123	2.1k
Michael Schuster United States	27	1.6k 2.1×	657 1.1×	871 1.8×	676 1.6×	171 0.6×	76	3.0k
Joseph A. Lasky United States	39	1.4k 1.8×	342 0.6×	191 0.4×	607 1.5×	320 1.1×	109	4.7k
Yasuhiro Maeda Japan	25	620 0.8×	326 0.5×	530 1.1×	428 1.0×	213 0.7×	147	2.6k
Pedro López‐Romero Spain	24	1.0k 1.3×	307 0.5×	136 0.3×	446 1.1×	224 0.8×	49	2.4k
Hiromi Hamada Japan	26	671 0.9×	231 0.4×	215 0.4×	220 0.5×	167 0.6×	146	2.5k
Robert J. Spiegel United States	23	800 1.0×	349 0.6×	207 0.4×	611 1.5×	103 0.4×	73	2.2k

Countries citing papers authored by Jingjin Li

Since Specialization

Citations

This map shows the geographic impact of Jingjin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjin Li more than expected).

Fields of papers citing papers by Jingjin Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjin Li. The network helps show where Jingjin Li may publish in the future.

Co-authorship network of co-authors of Jingjin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjin Li. A scholar is included among the top collaborators of Jingjin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjin Li. Jingjin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiang, Yue, Yi‐Wen Huang, Jing Xu, et al.. (2025). Uncovering Molecular Mechanisms of Feed Efficiency in Pigs Through Multi-Omics Analysis of the Jejunum. Animals. 15(2). 137–137.

Keudell, Gottfried von, Eliza A. Hawkes, Cecilia Carpio, et al.. (2024). Treatment Duration and Risk of Fatal Infections in Patients with B-Cell Non-Hodgkin Lymphoma Achieving Complete Response with Odronextamab. Blood. 144(Supplement 1). 3080–3080.

Baird, John H., Pim Mutsaers, Jeremy S. Abramson, et al.. (2023). Abstract CT129: Trial in progress: ATHENA-1 - a phase 1, open-label, first-in-human study to assess safety and tolerability of REGN5837 in combination with odronextamab in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphomas. Cancer Research. 83(8_Supplement). CT129–CT129. 2 indexed citations

Hu, Hongyu, et al.. (2023). Elevated level of high-sensitivity cardiac troponin I as a predictor of adverse cardiovascular events in patients with heart failure with preserved ejection fraction. Chinese Medical Journal. 136(18). 2195–2202. 1 indexed citations

Zhao, Changzhi, Zhen F. Fu, Yanan Fu, et al.. (2021). Genome-scale CRISPR screen identifies TMEM41B as a multi-function host factor required for coronavirus replication. PLoS Pathogens. 17(12). e1010113–e1010113. 43 indexed citations

Zhao, Yunxia, Ye Hou, Yueyuan Xu, et al.. (2021). A compendium and comparative epigenomics analysis of cis-regulatory elements in the pig genome. Nature Communications. 12(1). 2217–2217. 92 indexed citations

Cooper, Dennis, Deepu Madduri, Suzanne Lentzsch, et al.. (2019). Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 134(Supplement_1). 3176–3176. 31 indexed citations

Papadopoulos, Kyriakos P., Melissa L. Johnson, A. Craig Lockhart, et al.. (2019). First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies. Clinical Cancer Research. 26(5). 1025–1033. 50 indexed citations

Ren, Jie, et al.. (2019). Overexpression of CKIP-1 alleviates hypoxia-induced cardiomyocyte injury by up-regulating Nrf2 antioxidant signaling via Keap1 inhibition. Biochimie. 163. 163–170. 7 indexed citations

10.

Wu, Zhenyang, Xiaohui Tang, Sheng Wang, et al.. (2018). Profiles of miRNAs and target gene analysis with white and black skin tissues of the Tibetan sheep.. Zhongguo nongye Kexue. 51(2). 351–362. 1 indexed citations

11.

Hou, Ye, Liangliang Fu, Jingjin Li, et al.. (2018). Transcriptome Analysis of Potential miRNA Involved in Adipogenic Differentiation of C2C12 Myoblasts. Lipids. 53(4). 375–386. 19 indexed citations

12.

Li, Jingjin. (2014). Metabonomics Study on Antidepressant Effect of Banxia-houpo Decoction. Science Technology and Engineering. 1 indexed citations

13.

Li, Jingjin. (2014). Coping Style of Community Women with Urinary Incontinence and Its Influencing Factors. 1 indexed citations

14.

Li, Jingjin. (2014). Serum metabonomics study on toxicity of Fructus Toosendan. 1 indexed citations

15.

Li, Jingjin. (2013). The correlation analysis of gastrointestinal dysfunction with the severity and prognosis of sepsis. 1 indexed citations

16.

Colombo, Nicoletta, E. Kutarska, Meletios Α. Dimopoulos, et al.. (2012). Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer. Journal of Clinical Oncology. 30(31). 3841–3847. 95 indexed citations

17.

Wang, Zhu-Yao, Jingjin Li, Xiaojin Zhang, et al.. (2011). Essential role of ERK activation in neurite outgrowth induced by α-lipoic acid. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813(5). 827–838. 69 indexed citations

18.

Li, Jingjin, et al.. (2006). Factors Associated with Drug Adherence and Blood Pressure Control in Patients with Hypertension. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(4). 483–492. 127 indexed citations

19.

Tu, Wanzhu, Jingjin Li, Jingwei Wu, et al.. (2005). Association Between Adherence Measurements of Metoprolol and Health Care Utilization in Older Patients with Heart Failure*. Clinical Pharmacology & Therapeutics. 77(3). 189–201. 36 indexed citations

20.

Li, Jingjin, Ann Holmes, Marc B. Rosenman, et al.. (2005). Indiana Chronic Disease Management Program Risk Stratification Analysis. Medical Care. 43(10). 979–984. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact